Vaccine-induced antibodies may be less effective against several new SARS-CoV-2 variants: study

UN says Ebola in Guinea may be linked to 2014 outbreak
12 March 2021
India to make billion-plus vaccine doses with US, Japan, Australia
12 March 2021

Vaccine-induced antibodies may be less effective against several new SARS-CoV-2 variants: study

SARS-CoV-2, the virus that causes COVID-19, has mutated throughout the pandemic. New variants of the virus have arisen throughout the world, including variants that might possess increased ability to spread or evade the immune system. Such variants have been identified in California, Denmark, the U.K., South Africa and Brazil/Japan. Understanding how well the COVID-19 vaccines work against these variants is vital in the efforts to stop the global pandemic, and is the subject of new research from the Ragon Institute of MGH, MIT and Harvard and Massachusetts General Hospital.

Comments are closed.